Best Mid Cap Funds
Tomorrow's large caps. Higher growth, higher swings — reward the patient.
Data updated · 34 direct-growth funds ranked by a transparent 0–100 Smart Score
| ⚖ VS | Fund | Score ↓ | Verdict | 1Y | 3Y | 5Y | Sharpe | Sortino | Std Dev | Alpha | Beta | VR★ | P/E | Expense | AUM | Age |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Invesco India Midcap Invesco | 77 | Buy | 12.5% | 24.4% | 20.6% | 1.00 | 1.46 | 19.5 | 2.8 | 0.99 | 5★ | 48.3 | 0.74% | ₹14.7k Cr | 13.7y | |
| WhiteOak Capital Mid Cap WhiteOak | 77 | Buy | 17.4% | 23.1% | — | 1.12 | 1.41 | 17.3 | 4.3 | 0.89 | 5★ | 31.9 | 0.95% | ₹6.8k Cr | 4.0y | |
| HDFC Mid Cap HDFC | 76 | Buy | 10.8% | 18.6% | 19.9% | 1.03 | 1.08 | 16.0 | 2.4 | 0.83 | 4★ | 28.8 | 0.75% | ₹1.05L Cr | 13.7y | |
| HSBC Midcap HSBC | 75 | Buy | 24.1% | 25.4% | 19.6% | 1.09 | 1.36 | 20.0 | 4.8 | 1.01 | 4★ | 31.6 | 1.22% | ₹15.6k Cr | 13.7y | |
| Helios Mid Cap Helios | 75 | Buy | 15.1% | — | — | 1.24 | 1.80 | 16.0 | 6.3 | 0.93 | — | 44.8 | 0.93% | ₹2.0k Cr | 1.5y | |
| Edelweiss Midcap Edelweiss | 72 | Buy | 11.0% | 21.9% | 19.4% | 1.05 | 0.58 | 17.8 | 3.2 | 0.92 | 5★ | 31.8 | 0.71% | ₹18.7k Cr | 13.7y | |
| ICICI Pru Mid Cap ICICI Pru | 69 | Buy | 18.8% | 22.6% | 18.3% | 1.08 | 1.22 | 18.7 | 3.9 | 0.97 | 4★ | 35.2 | 1.13% | ₹8.0k Cr | 13.7y | |
| MahIndra Manulife Mid Cap Mahindra Manulife | 69 | Buy | 14.3% | 19.3% | 19.0% | 1.05 | 1.00 | 17.6 | 2.8 | 0.93 | 4★ | 33.9 | 0.76% | ₹5.2k Cr | 8.6y | |
| Baroda BNP Paribas Mid Cap Baroda BNP Paribas | 69 | Buy | 13.3% | 17.9% | 21.0% | 0.75 | 1.01 | 15.2 | 1.3 | 0.86 | 4★ | 30.1 | 0.74% | ₹2.6k Cr | 13.7y | |
| Nippon India Gr Mid Cap Nippon India | 68 | Buy | 10.5% | 19.4% | 18.9% | 1.01 | 1.03 | 18.1 | 2.4 | 0.95 | 5★ | 29.5 | 0.80% | ₹50.8k Cr | 13.7y | |
| Sundaram Midcap Sundaram | 61 | Hold | 9.9% | 19.6% | 17.6% | 1.01 | 0.83 | 17.5 | 2.2 | 0.92 | 4★ | 38.4 | 1.06% | ₹14.5k Cr | 13.7y | |
| Motilal Oswal Midcap Motilal Oswal | 59 | Hold | 0.4% | 19.0% | 22.3% | 0.70 | 1.21 | 20.4 | -1.2 | 0.92 | 4★ | 44.6 | 0.95% | ₹40.0k Cr | 12.5y | |
| ITI Mid Cap ITI | 58 | Hold | 15.5% | 21.3% | 17.0% | 0.97 | 1.07 | 19.1 | 1.8 | 1.00 | 3★ | 31.6 | 0.97% | ₹1.5k Cr | 5.5y | |
| JM Mid Cap JM | 56 | Hold | 13.7% | 19.5% | — | 0.95 | 0.98 | 19.4 | 1.9 | 0.99 | 4★ | 36.4 | 0.86% | ₹1.3k Cr | 3.8y | |
| Kotak Midcap Kotak | 56 | Hold | 8.8% | 18.5% | 17.3% | 0.87 | -0.13 | 18.0 | 0.3 | 0.91 | 4★ | 30.7 | 0.51% | ₹69.0k Cr | 13.7y | |
| Mirae Asset Midcap Mirae Asset | 52 | Hold | 13.7% | 17.1% | 16.3% | 0.66 | 0.88 | 16.0 | -0.3 | 0.91 | 3★ | 23.0 | 0.90% | ₹20.3k Cr | 7.2y | |
| Axis Midcap Axis | 51 | Hold | 9.4% | 17.1% | 13.7% | 0.72 | 0.98 | 14.8 | 0.1 | 0.83 | 4★ | 32.9 | 0.82% | ₹34.2k Cr | 13.7y | |
| Bandhan Midcap Bandhan | 48 | Hold | 12.4% | 18.6% | — | 0.83 | -0.36 | 18.7 | -0.5 | 0.95 | 3★ | 46.8 | 0.71% | ₹2.4k Cr | 4.0y | |
| Canara Robeco Mid Cap Canara Robeco | 48 | Hold | 7.9% | 17.7% | — | 0.68 | 0.94 | 16.2 | 0.3 | 0.92 | 4★ | 40.0 | 0.86% | ₹5.0k Cr | 3.8y | |
| Union Midcap Union | 44 | Avoid | 12.1% | 17.7% | 16.2% | 0.66 | 0.89 | 16.9 | -0.2 | 0.95 | 3★ | — | 1.14% | ₹1.9k Cr | 6.4y | |
| FranklIn India Mid Cap Franklin | 40 | Avoid | 4.7% | 16.5% | 14.4% | 0.63 | 0.86 | 15.5 | -0.6 | 0.88 | 3★ | 34.0 | 1.08% | ₹12.9k Cr | 13.7y | |
| Tata Mid Cap Tata | 40 | Avoid | 9.9% | 15.8% | 15.4% | 0.57 | 0.76 | 15.6 | -1.5 | 0.88 | 4★ | 36.8 | 0.84% | ₹6.1k Cr | 13.7y | |
| ABSL Midcap Gr Dir Aditya Birla Sun Life | 38 | Avoid | 11.1% | 16.2% | 15.0% | 0.61 | 0.83 | 15.6 | -0.8 | 0.88 | — | — | 1.22% | ₹6.7k Cr | 13.7y | |
| LIC MF Mid Cap LIC | 33 | Avoid | 10.4% | 17.2% | 13.7% | 0.64 | 0.87 | 16.7 | -0.4 | 0.93 | 4★ | 39.1 | 1.41% | ₹376 Cr | 9.6y | |
| DSP Midcap DSP | 33 | Avoid | 7.6% | 15.2% | 12.4% | 0.55 | 0.74 | 15.7 | -1.9 | 0.88 | 3★ | 22.2 | 0.81% | ₹20.5k Cr | 13.7y | |
| SBI Midcap SBI | 32 | Avoid | 7.6% | 11.8% | 14.2% | 0.38 | 0.51 | 13.4 | -4.0 | 0.74 | 2★ | 37.9 | 1.01% | ₹24.4k Cr | 13.7y | |
| Quant Midcap Gr Quant | 27 | Avoid | 8.1% | 12.4% | 16.3% | 0.32 | 0.42 | 17.1 | -5.3 | 0.90 | 4★ | 32.0 | 1.20% | ₹8.1k Cr | 13.7y | |
| PGIM India Midcap PGIM India | 27 | Avoid | 2.4% | 12.2% | 11.5% | 0.37 | 0.51 | 15.2 | -4.3 | 0.85 | 2★ | 29.4 | 0.77% | ₹11.1k Cr | 12.7y | |
| UTI Midcap Gr Dir UTI | 22 | Avoid | 7.0% | 12.9% | 12.8% | -0.09 | -0.12 | 17.3 | -2.0 | 1.00 | 3★ | 32.4 | 1.07% | ₹12.4k Cr | 13.7y | |
| Bank Of India Mid Cap Bank of India | 22 | Avoid | 6.5% | 14.8% | 12.5% | 0.51 | 0.68 | 15.6 | -2.1 | 0.86 | — | 30.9 | 1.33% | ₹733 Cr | 1.1y | |
| TrustMF Mid Cap Trust | 10 | Avoid | — | — | — | — | — | — | — | — | — | 44.6 | 1.86% | ₹429 Cr | 0.5y | |
| Taurus Mid Cap Taurus | 9 | Avoid | 7.0% | 9.9% | 12.8% | 0.17 | 0.22 | 18.4 | -8.9 | 1.01 | — | — | 2.21% | ₹135 Cr | 13.7y | |
| Samco Mid Cap Samco | 4 | Avoid | — | — | — | — | — | — | — | — | — | 16.8 | 1.87% | ₹79 Cr | 0.6y | |
| The Wealth Company Mid Cap The Wealth Company | 1 | Avoid | — | — | — | — | — | — | — | — | — | — | — | ₹0 Cr | 0.1y |
Mid Cap funds — quick answers
›Which is the best Mid Cap mutual fund right now?
Invesco India Midcap currently ranks #1 of 34 Mid Cap funds with a FundLens Smart Score of 77/100 (Buy). It returned 24.4% over 3 years and 20.6% over 5 years at a 0.74% expense ratio (direct plan). Rankings are recomputed from data updated 03 Sept 2026.
›Which Mid Cap fund has the best risk-adjusted returns?
Helios Mid Cap leads the category on the Sortino ratio at 1.80 (Sharpe 1.24) — meaning it has delivered the most return per unit of downside risk among Mid Cap funds.
›Which Mid Cap fund has the lowest expense ratio?
Kotak Midcap charges 0.51% a year (direct plan) — the lowest in the category. Lower fees compound in your favour over long holding periods.
›Which is the smallest Mid Cap fund by AUM?
The Wealth Company Mid Cap manages ₹0 Cr, the smallest in the category. Smaller funds can be nimbler, but check track record and costs before treating size alone as an edge.
›How long should I stay invested in a Mid Cap fund?
Mid Cap funds carry very high risk, so a horizon of 7+ years is generally sensible. Tomorrow's large caps. Higher growth, higher swings — reward the patient. This is research, not investment advice.
Visitors also asked
Want these answers conversationally? Ask FundLens · New to the ratios? Sharpe vs Sortino, explained